Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,748,898
+$229,296 QoQ
Shares Held
6,950
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#2,071
of 4,153 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grand Central Investment Group holds $5,851,538 across 3 Drug Manufacturers - General names. ABBV ranks #3 (29.9% of the industry book) .
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,748,898 | 6,950 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,519,602 | 6,987 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,606,056 | 7,029 | Shares | Sole | 2026-02-18 | |
| 2022-09-30 | $1,053,414 | 7,849 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,197,098 | 7,816 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,340,973 | 8,272 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,133,568 | 8,372 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $958,101 | 8,882 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,152,983 | 10,236 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,061,746 | 9,811 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,027,889 | 9,593 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||